Published in Bone Marrow Transplant on June 01, 1990
Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature (1976) 4.83
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A (1981) 2.86
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Y-antigen killing by T cells of women is restricted by HLA. Nature (1977) 2.73
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity (1997) 2.45
HLA-linked genetic control of host response to Mycobacterium leprae. Lancet (1976) 2.45
Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43
Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science (1988) 2.28
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science (1998) 2.11
Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene (2006) 2.09
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health (1992) 1.81
The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity (1997) 1.78
Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature (1992) 1.76
An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun (1999) 1.75
Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol (1999) 1.68
Conditional identification of phosphate-starvation-response mutants in Arabidopsis thaliana. Planta (2000) 1.68
Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol (2001) 1.66
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur J Immunol (1986) 1.62
Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens (1997) 1.62
Genetic basis of gluten-sentitive enteropathy. Gastroenterology (1978) 1.60
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
The serological recognition of the human MLC determinants using a modified cytotoxicity technique. Tissue Antigens (1975) 1.54
Disentangling the causal inter-relationship between negative life events and depressive symptoms in women: a longitudinal twin study. Psychol Med (2012) 1.49
Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem (1995) 1.48
A gene for dihydrofolate reductase in a herpesvirus. Science (1988) 1.47
Possible implications of the effect of blood transfusion on allograft survival. Lancet (1983) 1.46
Non-puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol (1997) 1.46
In vitro immune responsiveness to vaccinea virus and HLA. N Engl J Med (1977) 1.43
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43
Anti HL-A2 inhibitor in normal human serum. Nature (1970) 1.40
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol (1999) 1.38
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet (1977) 1.37
Characterization of two classes of ribonucleoprotein complexes possibly involved in RNA editing from Leishmania tarentolae mitochondria. EMBO J (1994) 1.36
A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature (1983) 1.34
Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. Ann Rheum Dis (1984) 1.33
Mixed lymphocyte culture and HL-A. Transplant Proc (1972) 1.33
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem (1994) 1.33
HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol (1982) 1.30
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
Genetic control of survival in epidemics. J Immunogenet (1979) 1.28
HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis (1985) 1.28
The major histocompatibility complex - genetics and biology (third of three parts). N Engl J Med (1976) 1.28
Typing for MLC (LD). II. The selection of nonstimulator cells by MLC inhibition tests using SD-indentical stimulator cells (MISIS) and fluorescence antibody studies. Transplant Proc (1973) 1.26
The HL-A system. I. Genetics and molecular biology. Semin Hematol (1974) 1.26
Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer (1987) 1.25
Efficacy of HL-A matching in Eurotransplant. Lancet (1972) 1.25
Cell-mediated lympholysis studies in renal allograft recipients. Transplantation (1981) 1.25
The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix. Int J Gynecol Pathol (1997) 1.24
Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records. Neth J Med (1999) 1.22
Alloimmunity to human H-Y. Lancet (1976) 1.20
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet (1990) 1.19
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Hum Pathol (1998) 1.18
Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens (1998) 1.18
Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene (1999) 1.18
Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. N Engl J Med (1982) 1.18
Mechanisms of gene-environment interactions in depression: evidence that genes potentiate multiple sources of adversity. Psychol Med (2008) 1.16
IgM-IgG cryoglobulinaemia with IgM paraprotein component. Clin Exp Immunol (1968) 1.15
Mapping of RNA transcribed from a region of the Herpesvirus saimiri genome required for oncogenicity. J Virol (1984) 1.14
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol (2001) 1.14
Platelet and granulocyte specific allo-antigens in chimpanzees. Tissue Antigens (1983) 1.14
T-DNA organization in homogeneous and heterogeneous octopine-type crown gall tissues of Nicotiana tabacum. Cell (1982) 1.14
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med (1998) 1.14
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Letter: HL-A 27 and ankylosing spondylitis. Lancet (1975) 1.13
Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol (1995) 1.12
Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A (2001) 1.11
Scenario analysis of the future of medicines. BMJ (1994) 1.11
Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg (1993) 1.10
Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data. Pharm World Sci (1995) 1.10
Anti-self HLA may be clonally expressed. J Exp Med (1979) 1.10
Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol (2000) 1.10
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Graft survival in unrelated donor--recipient pairs matched for MLC and HL-A. Transplant Proc (1973) 1.09
Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation (1990) 1.09
Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol (1996) 1.09
Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood (1994) 1.08
Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. Arch Pediatr Adolesc Med (1998) 1.08